|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
3
|
McLean MH and El-Omar EM: Genetics of
gastric cancer. Nat Rev Gastroenterol Hepatol. 11:664–674. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Okada F: Inflammation-related
carcinogenesis: Current findings in epidemiological trends, causes
and mechanisms. Yonago Acta Med. 57:65–72. 2014.PubMed/NCBI
|
|
6
|
De Flora S and Bonanni P: The prevention
of infection-associated cancers. Carcinogenesis. 32:787–795. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Trinchieri G: Cancer and inflammation: An
old intuition with rapidly evolving new concepts. Annu Rev Immunol.
30:677–706. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Correa P: Helicobacter pylori and gastric
carcinogenesis. Am J Surg Pathol. 19(Suppl 1): S37–S43.
1995.PubMed/NCBI
|
|
10
|
Yakirevich E and Resnick MB: Pathology of
gastric cancer and its precursor lesions. Gastroenterol Clin North
Am. 42:261–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Piazuelo MB and Correa P: Gastric cáncer:
Overview. Colomb Med (Cali). 44:192–201. 2013.
|
|
12
|
Grabsch HI and Tan P: Gastric cancer
pathology and underlying molecular mechanisms. Dig Surg.
30:150–158. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang B, Kang H, Fung A, Zhao H, Wang T and
Ma D: The role of interleukin 17 in tumour proliferation,
angiogenesis, and metastasis. Mediators Inflamm. 2014:6237592014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang B, Rong G, Wei H, Zhang M, Bi J, Ma
L, Xue X, Wei G, Liu X and Fang G: The prevalence of Th17 cells in
patients with gastric cancer. Biochem Biophys Res Commun.
374:533–537. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu P, Wu D, Ni C, Ye J, Chen W, Hu G, Wang
Z, Wang C, Zhang Z, Xia W, et al: γδT17 cells promote the
accumulation and expansion of myeloid-derived suppressor cells in
human colorectal cancer. Immunity. 40:785–800. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He D, Li H, Yusuf N, Elmets CA, Li J,
Mountz JD and Xu H: IL-17 promotes tumor development through the
induction of tumor promoting microenvironments at tumor sites and
myeloid-derived suppressor cells. J Immunol. 184:2281–2288. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miyahara Y, Odunsi K, Chen W, Peng G,
Matsuzaki J and Wang RF: Generation and regulation of human
CD4+ IL-17-producing T cells in ovarian cancer. Proc
Natl Acad Sci USA. 105:15505–15510. 2008. View Article : Google Scholar
|
|
19
|
Langowski JL, Zhang X, Wu L, Mattson JD,
Chen T, Smith K, Basham B, McClanahan T, Kastelein RA and Oft M:
IL-23 promotes tumour incidence and growth. Nature. 442:461–465.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alizadeh D, Katsanis E and Larmonier N:
The multifaceted role of Th17 lymphocytes and their associated
cytokines in cancer. Clin Dev Immunol. 2013:9578782013. View Article : Google Scholar
|
|
21
|
Liu X, Jin H, Zhang G, Lin X, Chen C, Sun
J, Zhang Y, Zhang Q and Yu J: Intratumor IL-17-positive mast cells
are the major source of the IL-17 that is predictive of survival in
gastric cancer patients. PLoS One. 9:e1068342014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lockhart E, Green AM and Flynn JL: IL-17
production is dominated by gammadelta T cells rather than CD4 T
cells during Mycobacterium tuberculosis infection. J Immunol.
177:4662–4669. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu SJ, Tsai JP, Shen CR, Sher YP, Hsieh
CL, Yeh YC, Chou AH, Chang SR, Hsiao KN, Yu FW, et al: Induction of
a distinct CD8 Tnc17 subset by transforming growth factor-beta and
interleukin-6. J Leukoc Biol. 82:354–360. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoshiga Y, Goto D, Segawa S, Ohnishi Y,
Matsumoto I, Ito S, Tsutsumi A, Taniguchi M and Sumida T: Invariant
NKT cells produce IL-17 through IL-23-dependent and -independent
pathways with potential modulation of Th17 response in
collagen-induced arthritis. Int J Mol Med. 22:369–374.
2008.PubMed/NCBI
|
|
25
|
Wang B, Li L, Liao Y, Li J, Yu X, Zhang Y,
Xu J, Rao H, Chen S, Zhang L, et al: Mast cells expressing
interleukin 17 in the muscularis propria predict a favorable
prognosis in esophageal squamous cell carcinoma. Cancer Immunol
Immunother. 62:1575–1585. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang JP, Yan J, Xu J, Pang XH, Chen MS,
Li L, Wu C, Li SP and Zheng L: Increased intratumoral
IL-17-producing cells correlate with poor survival in
hepatocellular carcinoma patients. J Hepatol. 50:980–989. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kuang DM, Peng C, Zhao Q, Wu Y, Zhu LY,
Wang J, Yin XY, Li L and Zheng L: Tumor-activated monocytes promote
expansion of IL-17-producing CD8+ T cells in
hepatocellular carcinoma patients. J Immunol. 185:1544–1549. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Grivennikov SI, Wang K, Mucida D, Stewart
CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung
KE, et al: Adenoma-linked barrier defects and microbial products
drive IL-23/IL-17-mediated tumour growth. Nature. 491:254–258.
2012.PubMed/NCBI
|
|
29
|
Zhuang Y, Peng LS, Zhao YL, Shi Y, Mao XH,
Chen W, Pang KC, Liu XF, Liu T, Zhang JY, et al: CD8(+) T cells
that produce interleukin-17 regulate myeloid-derived suppressor
cells and are associated with survival time of patients with
gastric cancer. Gastroenterology. 143:951–962. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iida T, Iwahashi M, Katsuda M, Ishida K,
Nakamori M, Nakamura M, Naka T, Ojima T, Ueda K, Hayata K, et al:
Tumor-infiltrating CD4+ Th17 cells produce IL-17 in
tumor microenvironment and promote tumor progression in human
gastric cancer. Oncol Rep. 25:1271–1277. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fouser LA, Wright JF, Dunussi-Joannopoulos
K and Collins M: Th17 cytokines and their emerging roles in
inflammation and autoimmunity. Immunol Rev. 226:87–102. 2008.
View Article : Google Scholar
|
|
32
|
Wilke CM, Bishop K, Fox D and Zou W:
Deciphering the role of Th17 cells in human disease. Trends
Immunol. 32:603–611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Muranski P and Restifo NP: Essentials of
Th17 cell commitment and plasticity. Blood. 121:2402–2414. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kryczek I, Banerjee M, Cheng P, Vatan L,
Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH, et
al: Phenotype, distribution, generation, and functional and
clinical relevance of Th17 cells in the human tumor environments.
Blood. 114:1141–1149. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sfanos KS, Bruno TC, Maris CH, Xu L,
Thoburn CJ, DeMarzo AM, Meeker AK, Isaacs WB and Drake CG:
Phenotypic analysis of prostate-infiltrating lymphocytes reveals
TH17 and Treg skewing. Clin Cancer Res. 14:3254–3261. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ye ZJ, Zhou Q, Gu YY, Qin SM, Ma WL, Xin
JB, Tao XN and Shi HZ: Generation and differentiation of
IL-17-producing CD4+ T cells in malignant pleural
effusion. J Immunol. 185:6348–6354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gnerlich JL, Mitchem JB, Weir JS, Sankpal
NV, Kashiwagi H, Belt BA, Porembka MR, Herndon JM, Eberlein TJ,
Goedegebuure P, et al: Induction of Th17 cells in the tumor
microenvironment improves survival in a murine model of pancreatic
cancer. J Immunol. 185:4063–4071. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Muranski P, Boni A, Antony PA, Cassard L,
Irvine KR, Kaiser A, Paulos CM, Palmer DC, Touloukian CE, Ptak K,
et al: Tumor-specific Th17-polarized cells eradicate large
established melanoma. Blood. 112:362–373. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nigam P, Kwa S, Velu V and Amara RR: Loss
of IL-17-producing CD8 T cells during late chronic stage of
pathogenic simian immunodeficiency virus infection. J Immunol.
186:745–753. 2011. View Article : Google Scholar
|
|
40
|
Hamada H, Garcia-Hernandez ML, Reome JB,
Misra SK, Strutt TM, McKinstry KK, Cooper AM, Swain SL and Dutton
RW: Tc17, a unique subset of CD8 T cells that can protect against
lethal influenza challenge. J Immunol. 182:3469–3481. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tajima M, Wakita D, Noguchi D, Chamoto K,
Yue Z, Fugo K, Ishigame H, Iwakura Y, Kitamura H and Nishimura T:
IL-6-dependent spontaneous proliferation is required for the
induction of colitogenic IL-17-producing CD8+ T cells. J
Exp Med. 205:1019–1027. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tzartos JS, Friese MA, Craner MJ, Palace
J, Newcombe J, Esiri MM and Fugger L: Interleukin-17 production in
central nervous system-infiltrating T cells and glial cells is
associated with active disease in multiple sclerosis. Am J Pathol.
172:146–155. 2008. View Article : Google Scholar :
|
|
43
|
Hinrichs CS, Kaiser A, Paulos CM, Cassard
L, Sanchez-Perez L, Heemskerk B, Wrzesinski C, Borman ZA, Muranski
P and Restifo NP: Type 17 CD8+ T cells display enhanced
antitumor immunity. Blood. 114:596–599. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang Y, Hou F, Liu X, Ma D, Zhang Y, Kong
B and Cui B: Tc17 cells in patients with uterine cervical cancer.
PLoS One. 9:e868122014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang W, Hou F, Zhang Y, Tian Y, Jiao J,
Ma D, Kong B and Cui B: Changes of Th17/Tc17 and Th17/Treg cells in
endometrial carcinoma. Gynecol Oncol. 132:599–605. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yu Y, Cho HI, Wang D, Kaosaard K, Anasetti
C, Celis E and Yu XZ: Adoptive transfer of Tc1 or Tc17 cells
elicits antitumor immunity against established melanoma through
distinct mechanisms. J Immunol. 190:1873–1881. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Garcia-Hernandez ML, Hamada H, Reome JB,
Misra SK, Tighe MP and Dutton RW: Adoptive transfer of
tumor-specific Tc17 effector T cells controls the growth of B16
melanoma in mice. J Immunol. 184:4215–4227. 2010. View Article : Google Scholar
|
|
48
|
Jiang G, Ma S, Wei Y, Wu Y, Yu X and Liu
H: The prevalence and distribution of Th17 and Tc17 cells in
patients with thyroid tumor. Immunol Lett. 162:68–73. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Petermann F, Rothhammer V, Claussen MC,
Haas JD, Blanco LR, Heink S, Prinz I, Hemmer B, Kuchroo VK, Oukka
M, et al: γδ T cells enhance autoimmunity by restraining regulatory
T cell responses via an interleukin-23-dependent mechanism.
Immunity. 33:351–363. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sutton CE, Lalor SJ, Sweeney CM, Brereton
CF, Lavelle EC and Mills KH: Interleukin-1 and IL-23 induce innate
IL-17 production from gammadelta T cells, amplifying Th17 responses
and autoimmunity. Immunity. 31:331–341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cai Y, Shen X, Ding C, Qi C, Li K, Li X,
Jala VR, Zhang HG, Wang T, Zheng J, et al: Pivotal role of dermal
IL-17-producing γδ T cells in skin inflammation. Immunity.
35:596–610. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ito Y, Usui T, Kobayashi S,
Iguchi-Hashimoto M, Ito H, Yoshitomi H, Nakamura T, Shimizu M,
Kawabata D, Yukawa N, et al: Gamma/delta T cells are the
predominant source of interleukin-17 in affected joints in
collagen-induced arthritis, but not in rheumatoid arthritis.
Arthritis Rheum. 60:2294–2303. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wakita D, Sumida K, Iwakura Y, Nishikawa
H, Ohkuri T, Chamoto K, Kitamura H and Nishimura T:
Tumor-infiltrating IL-17-producing gammadelta T cells support the
progression of tumor by promoting angiogenesis. Eur J Immunol.
40:1927–1937. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Miossec P: IL-17 and Th17 cells in human
inflammatory diseases. Microbes Infect. 11:625–630. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tesmer LA, Lundy SK, Sarkar S and Fox DA:
Th17 cells in human disease. Immunol Rev. 223:87–113. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Korn T, Bettelli E, Oukka M and Kuchroo
VK: IL-17 and Th17 cells. Annu Rev Immunol. 27:485–517. 2009.
View Article : Google Scholar : PubMed/NCBI
|
